| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RAPGEF6 RASA1 MYO9A DOCK8 ITSN1 LRRK2 SRGAP2 DENND4C CCDC88C TBC1D4 ARHGEF10 ARHGEF1 RASGEF1B RAPGEF2 ARAP2 MTSS2 | 1.05e-05 | 507 | 175 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RAPGEF6 RASA1 MYO9A DOCK8 ITSN1 LRRK2 SRGAP2 DENND4C CCDC88C TBC1D4 ARHGEF10 ARHGEF1 RASGEF1B RAPGEF2 ARAP2 MTSS2 | 1.05e-05 | 507 | 175 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RAPGEF6 DOCK8 ITSN1 DENND4C CCDC88C ARHGEF10 ARHGEF1 RASGEF1B RAPGEF2 | 2.08e-04 | 231 | 175 | 9 | GO:0005085 |
| GeneOntologyBiologicalProcess | negative regulation of defense response to bacterium | 1.16e-05 | 6 | 174 | 3 | GO:1900425 | |
| Domain | Cnn_1N | 2.51e-04 | 3 | 172 | 2 | IPR012943 | |
| Domain | srGAP2 | 2.51e-04 | 3 | 172 | 2 | IPR030252 | |
| Domain | Cnn_1N | 2.51e-04 | 3 | 172 | 2 | PF07989 | |
| Domain | RA | 3.25e-04 | 36 | 172 | 4 | PF00788 | |
| Domain | RA | 3.62e-04 | 37 | 172 | 4 | PS50200 | |
| Domain | RA_dom | 4.90e-04 | 40 | 172 | 4 | IPR000159 | |
| Domain | TEA_1 | 5.00e-04 | 4 | 172 | 2 | PS00554 | |
| Domain | TEA_2 | 5.00e-04 | 4 | 172 | 2 | PS51088 | |
| Domain | G8_domain | 5.00e-04 | 4 | 172 | 2 | IPR019316 | |
| Domain | TEA | 5.00e-04 | 4 | 172 | 2 | PF01285 | |
| Domain | TEA/ATTS_dom | 5.00e-04 | 4 | 172 | 2 | IPR000818 | |
| Domain | TEF_metazoa | 5.00e-04 | 4 | 172 | 2 | IPR016361 | |
| Domain | G8 | 5.00e-04 | 4 | 172 | 2 | PS51484 | |
| Domain | G8 | 5.00e-04 | 4 | 172 | 2 | SM01225 | |
| Domain | TEA | 5.00e-04 | 4 | 172 | 2 | SM00426 | |
| Domain | G8 | 5.00e-04 | 4 | 172 | 2 | PF10162 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | RPL28 EPPK1 AFF2 MYO9A LAMA1 LRRK2 MYO18A RNF213 HELQ PRDM2 CCDC88C TBC1D4 CDK5RAP2 | 6.22e-11 | 208 | 177 | 13 | 33230847 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPGEF6 MYO9A ZNF629 SRGAP2 VIRMA DENND4C CCDC88C KSR1 ZNF106 ESYT2 TBC1D4 MDN1 ARHGEF10 IKBKE ARHGEF1 OSBPL6 FAM83G RAPGEF2 ARAP2 MTSS2 TPD52L1 CCSER1 | 6.17e-10 | 861 | 177 | 22 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAPGEF6 ITSN1 POLR2A MYO18A ISL2 HUWE1 POLA2 VIRMA PRDM2 PITPNM1 ZNF106 MYOF ESYT2 TBC1D4 MDN1 USP42 MKI67 OTUD4 PRKDC | 1.87e-08 | 774 | 177 | 19 | 15302935 |
| Pubmed | SETMAR ACO1 ITSN1 SPTB ZNF189 DYNC2I1 SRGAP2 HUWE1 CBR1 BHLHE40 ARG2 STX1A HEATR6 TTC7B ZNF660 ARHGEF10 PDE4DIP MAST1 PRKDC JAKMIP1 RAPGEF2 DYNC1H1 RNF111 | 1.79e-07 | 1285 | 177 | 23 | 35914814 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ENGASE TEAD2 FRAS1 RAPGEF6 EPPK1 PCNX3 POLR2A SRGAP2 HUWE1 ZZEF1 CCDC88C MYOF MDN1 MTMR14 IER5L NFKB2 PRKDC MAPKBP1 ZNF426 DYNC1H1 ABCC10 | 2.43e-07 | 1105 | 177 | 21 | 35748872 |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 17724084 | ||
| Pubmed | RAPGEF6 DOCK8 SRGAP2 TEAD1 DENND4C CCDC88C KSR1 TBC1D4 ACAD11 PRKDC RAPGEF2 TPD52L1 NIN | 5.44e-07 | 446 | 177 | 13 | 24255178 | |
| Pubmed | USP36 POLR2A ZNF629 MCC RNF213 WDR37 ZZEF1 DNTTIP2 ARG2 KSR1 TADA1 ACAD11 PRPF4 LTN1 ADAM17 OSMR RAPGEF2 CLSPN ARAP2 NIN | 1.19e-06 | 1116 | 177 | 20 | 31753913 | |
| Pubmed | Distinct timing of neurogenesis of ipsilateral and contralateral retinal ganglion cells. | 1.29e-06 | 5 | 177 | 3 | 29761490 | |
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 31811168 | ||
| Pubmed | USP36 RPL28 AFF2 CCDC186 LRRK2 RNF213 HUWE1 PKHD1L1 MKI67 CDK5RAP2 PRKDC RAPGEF2 CLSPN SCLT1 DYNC1H1 ARAP2 | 2.59e-06 | 777 | 177 | 16 | 35844135 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | DYNC2I1 HUWE1 BHLHE40 DENND4C TBC1D4 NFKB2 RAPGEF2 CLSPN DYNC1H1 | 3.24e-06 | 232 | 177 | 9 | 25515538 |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 5.42e-06 | 132 | 177 | 7 | 16944949 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | SETMAR MYO9A ISG20 TRIM29 WDR37 BHLHE40 VIRMA KIF24 DENND4C PITPNM1 ZNF106 FARSA MDN1 USP42 ARHGEF1 CDK5RAP2 ADAM17 MST1L ARAP2 MTSS2 | 5.90e-06 | 1242 | 177 | 20 | 30973865 |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 6.34e-06 | 190 | 177 | 8 | 15161933 | |
| Pubmed | Overlapping functions of SIX homeoproteins during embryonic myogenesis. | 6.36e-06 | 24 | 177 | 4 | 37267426 | |
| Pubmed | 7.54e-06 | 25 | 177 | 4 | 22411557 | ||
| Pubmed | CBLL1 CACNB1 ITSN1 MCC SRGAP2 HUWE1 VIRMA CCDC88C FARSA MDN1 PDE4DIP OTUD4 CDK5RAP2 JAKMIP1 RAPGEF2 DYNC1H1 MTSS2 | 9.54e-06 | 963 | 177 | 17 | 28671696 | |
| Pubmed | 1.06e-05 | 9 | 177 | 3 | 20357111 | ||
| Pubmed | RPL28 MYO9A DOCK8 ITSN1 SPTB MYO18A SRGAP2 MTHFS WDR37 CBR1 VIRMA PITPNM1 FARSA TTC7B ARHGEF1 PDE4DIP OSBPL6 OTUD4 MAST1 RAPGEF2 DYNC1H1 | 1.39e-05 | 1431 | 177 | 21 | 37142655 | |
| Pubmed | Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. | 1.51e-05 | 10 | 177 | 3 | 19826009 | |
| Pubmed | 1.51e-05 | 10 | 177 | 3 | 24381269 | ||
| Pubmed | 1.51e-05 | 10 | 177 | 3 | 28215559 | ||
| Pubmed | 1.60e-05 | 104 | 177 | 6 | 9205841 | ||
| Pubmed | 2.08e-05 | 11 | 177 | 3 | 27224017 | ||
| Pubmed | 2.08e-05 | 11 | 177 | 3 | 29569362 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 29801480 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24858808 | ||
| Pubmed | Testis-enriched kinesin KIF9 is important for progressive motility in mouse spermatozoa. | 2.58e-05 | 2 | 177 | 2 | 32072696 | |
| Pubmed | CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutations. | 2.58e-05 | 2 | 177 | 2 | 29456132 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 8253797 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 38581027 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 36218033 | ||
| Pubmed | Requirement for SNAPC1 in transcriptional responsiveness to diverse extracellular signals. | 2.58e-05 | 2 | 177 | 2 | 22966203 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 32600317 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ITSN1 POLR2A BCORL1 LAMA1 RNF213 HUWE1 ZZEF1 QRICH2 PRDM2 TBC1D4 MDN1 PRKDC JAKMIP1 DYNC1H1 | 2.69e-05 | 736 | 177 | 14 | 29676528 |
| Pubmed | Netrin1/DCC signaling promotes neuronal migration in the dorsal spinal cord. | 2.76e-05 | 12 | 177 | 3 | 27784329 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RPL28 MYH7 EPPK1 MYO18A HUWE1 TRIM29 CBR1 ESYT2 MDN1 LTN1 ADAM17 PRKDC DYNC1H1 | 3.00e-05 | 647 | 177 | 13 | 26618866 |
| Pubmed | 3.57e-05 | 13 | 177 | 3 | 33984529 | ||
| Pubmed | 3.57e-05 | 13 | 177 | 3 | 15590934 | ||
| Pubmed | 3.57e-05 | 13 | 177 | 3 | 25943695 | ||
| Pubmed | 3.57e-05 | 13 | 177 | 3 | 19766572 | ||
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 3.57e-05 | 13 | 177 | 3 | 17920017 | |
| Pubmed | 3.57e-05 | 13 | 177 | 3 | 16438966 | ||
| Pubmed | A Second Heart Field-Derived Vasculogenic Niche Contributes to Cardiac Lymphatics. | 3.57e-05 | 13 | 177 | 3 | 31928974 | |
| Pubmed | 4.45e-05 | 76 | 177 | 5 | 27542412 | ||
| Pubmed | 4.53e-05 | 14 | 177 | 3 | 18223201 | ||
| Pubmed | p190RhoGAP Filters Competing Signals to Resolve Axon Guidance Conflicts. | 4.53e-05 | 14 | 177 | 3 | 30902550 | |
| Pubmed | 4.53e-05 | 14 | 177 | 3 | 21674568 | ||
| Pubmed | A novel view of the transcriptome revealed from gene trapping in mouse embryonic stem cells. | 5.14e-05 | 40 | 177 | 4 | 17540781 | |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 5.18e-05 | 128 | 177 | 6 | 25332235 | |
| Pubmed | RPL28 FLT4 THSD7A DOCK8 ITSN1 HUWE1 TRIM29 ZZEF1 ZNF106 PDE4DIP DYNC1H1 RNF111 | 5.52e-05 | 591 | 177 | 12 | 15231748 | |
| Pubmed | Determination of retinal cell fates is affected in the absence of extraocular striated muscles. | 5.64e-05 | 15 | 177 | 3 | 12619134 | |
| Pubmed | 5.64e-05 | 15 | 177 | 3 | 18303054 | ||
| Pubmed | 5.64e-05 | 15 | 177 | 3 | 17400507 | ||
| Pubmed | RPL28 POLR2A MYO18A RNF213 WDR37 ARHGEF10 ARHGEF1 NFKB2 OTUD4 UHRF1 PRKDC DYNC1H1 | 6.48e-05 | 601 | 177 | 12 | 33658012 | |
| Pubmed | 6.91e-05 | 16 | 177 | 3 | 27223328 | ||
| Pubmed | Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development. | 6.91e-05 | 16 | 177 | 3 | 25433207 | |
| Pubmed | 6.91e-05 | 16 | 177 | 3 | 22542185 | ||
| Pubmed | 6.91e-05 | 16 | 177 | 3 | 19800948 | ||
| Pubmed | 7.62e-05 | 199 | 177 | 7 | 23382691 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 22559944 | ||
| Pubmed | Differential Islet-1 expression among lumbosacral spinal motor neurons in prenatal mouse. | 7.70e-05 | 3 | 177 | 2 | 19236857 | |
| Pubmed | A new Prdm1-Cre line is suitable for studying the second heart field development. | 7.70e-05 | 3 | 177 | 2 | 38880275 | |
| Pubmed | Initial trajectories of sensory axons toward laminar targets in the developing mouse spinal cord. | 7.70e-05 | 3 | 177 | 2 | 9100133 | |
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 24811913 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 26951213 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 23686485 | ||
| Pubmed | Islet-1 expression in thoracic spinal motor neurons in prenatal mouse. | 7.70e-05 | 3 | 177 | 2 | 21651972 | |
| Pubmed | STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets. | 7.70e-05 | 3 | 177 | 2 | 15223310 | |
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 24591570 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 20053920 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 29747665 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 10934189 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 25588835 | ||
| Pubmed | HUWE1-dependent DNA-PKcs neddylation modulates its autophosphorylation in DNA damage response. | 7.70e-05 | 3 | 177 | 2 | 32457294 | |
| Pubmed | Expression of sorting nexin 18 (SNX18) is dynamically regulated in developing spinal motor neurons. | 7.70e-05 | 3 | 177 | 2 | 21339182 | |
| Pubmed | IkappaB kinase epsilon interacts with p52 and promotes transactivation via p65. | 7.70e-05 | 3 | 177 | 2 | 17003035 | |
| Pubmed | Wnt5a and Wnt11 are essential for second heart field progenitor development. | 8.36e-05 | 17 | 177 | 3 | 22569553 | |
| Pubmed | 8.36e-05 | 17 | 177 | 3 | 22318233 | ||
| Pubmed | USP36 POLR2A RNF213 HUWE1 ESYT2 TBC1D4 PTPRB TTC7B MTMR14 PRPF4 LTN1 MKI67 OTUD4 CDK5RAP2 ELP2 NIN | 9.95e-05 | 1049 | 177 | 16 | 27880917 | |
| Pubmed | 9.95e-05 | 144 | 177 | 6 | 35681168 | ||
| Pubmed | The graded response to Sonic Hedgehog depends on cilia architecture. | 1.00e-04 | 18 | 177 | 3 | 17488627 | |
| Pubmed | 1.00e-04 | 18 | 177 | 3 | 20602751 | ||
| Pubmed | 1.00e-04 | 18 | 177 | 3 | 26387456 | ||
| Pubmed | Disruption of a ciliary B9 protein complex causes Meckel syndrome. | 1.00e-04 | 18 | 177 | 3 | 21763481 | |
| Pubmed | PIK3AP1 ITSN1 POLR2A MCC DYNC2I1 RNF213 SRGAP2 HUWE1 DENND4C ZNF106 FARSA ARHGEF10 CLSPN | 1.06e-04 | 733 | 177 | 13 | 34672954 | |
| Pubmed | 1.11e-04 | 92 | 177 | 5 | 37343697 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 USP36 RPL28 POLR2A BCORL1 ZNF629 TEAD1 BHLHE40 DNTTIP2 PRDM2 ZNF106 ESYT2 MDN1 USP42 PRPF4 MKI67 UHRF1 PRKDC | 1.16e-04 | 1294 | 177 | 18 | 30804502 |
| Pubmed | Asb2α-Filamin A Axis Is Essential for Actin Cytoskeleton Remodeling During Heart Development. | 1.18e-04 | 19 | 177 | 3 | 29374072 | |
| Pubmed | m6A regulation of cortical and retinal neurogenesis is mediated by the redundant m6A readers YTHDFs. | 1.18e-04 | 19 | 177 | 3 | 36039295 | |
| Pubmed | Oligodendrocyte precursors migrate along vasculature in the developing nervous system. | 1.39e-04 | 20 | 177 | 3 | 26798014 | |
| Pubmed | Runx1 expression defines a subpopulation of displaced amacrine cells in the developing mouse retina. | 1.39e-04 | 20 | 177 | 3 | 16026391 | |
| Pubmed | 1.39e-04 | 20 | 177 | 3 | 18978355 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | RPL28 ACO1 RNF213 FARSA MTMR14 PDE4DIP OTUD4 PRKDC KRT25 DYNC1H1 CCSER1 | 1.46e-04 | 558 | 177 | 11 | 27591049 |
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 1.53e-04 | 4 | 177 | 2 | 22559943 | |
| Pubmed | 1.53e-04 | 4 | 177 | 2 | 33581058 | ||
| Pubmed | 1.53e-04 | 4 | 177 | 2 | 28067314 | ||
| Pubmed | 1.53e-04 | 4 | 177 | 2 | 23873932 | ||
| Pubmed | 1.53e-04 | 4 | 177 | 2 | 30685539 | ||
| Interaction | YWHAG interactions | BNIP5 RAPGEF6 RPS6KA4 MYO9A TNIP2 LRRK2 ZNF629 MCC SRGAP2 HUWE1 WDR37 VIRMA DENND4C DNTTIP2 CCDC88C KSR1 DFFA ZNF106 ESYT2 TBC1D4 MDN1 ARHGEF1 OSBPL6 FAM83G PRKDC JAKMIP1 RAPGEF2 DYNC1H1 ARAP2 MTSS2 TPD52L1 CCSER1 | 1.95e-08 | 1248 | 172 | 32 | int:YWHAG |
| Interaction | YWHAH interactions | RAPGEF6 EPPK1 RPS6KA4 MYO9A LRRK2 ZNF629 SRGAP2 HUWE1 POLA2 WDR37 VIRMA DENND4C CCDC88C KSR1 ZNF106 ESYT2 TBC1D4 IKBKE OSBPL6 FAM83G MAST1 JAKMIP1 RAPGEF2 ARAP2 MTSS2 TPD52L1 CCSER1 NIN | 2.08e-07 | 1102 | 172 | 28 | int:YWHAH |
| Interaction | YWHAZ interactions | CPA6 BNIP5 RAPGEF6 MYO9A LRRK2 MYO18A ZNF629 MCC SRGAP2 HUWE1 WDR37 CBR1 VIRMA DENND4C CCDC88C KSR1 DFFA TBC1D4 OSBPL6 FAM83G OTUD4 MAST1 CDK5RAP2 JAKMIP1 RAPGEF2 DYNC1H1 ARAP2 MTSS2 TPD52L1 CCSER1 NIN | 2.36e-07 | 1319 | 172 | 31 | int:YWHAZ |
| Interaction | YWHAQ interactions | CBLL1 MYH7 RAPGEF6 EPPK1 RPS6KA4 MYO9A SPTB LRRK2 ZNF629 SRGAP2 WDR37 VIRMA DENND4C CCDC88C KSR1 ZNF106 TBC1D4 USP42 PRPF4 OSBPL6 FAM83G PRKDC RAPGEF2 DYNC1H1 ARAP2 MTSS2 TPD52L1 CCSER1 | 2.78e-07 | 1118 | 172 | 28 | int:YWHAQ |
| Interaction | YWHAB interactions | RAPGEF6 RPS6KA4 MYO9A LRRK2 ZNF629 MCC SRGAP2 WDR37 VIRMA DENND4C CCDC88C KSR1 ZNF106 ESYT2 TBC1D4 OSBPL6 FAM83G MAST1 JAKMIP1 RAPGEF2 DYNC1H1 ARAP2 MTSS2 TPD52L1 CCSER1 | 1.74e-06 | 1014 | 172 | 25 | int:YWHAB |
| Interaction | YWHAE interactions | BNIP5 CACNB1 RAPGEF6 MYO9A DOCK8 TNIP2 LRRK2 ZNF629 MCC SRGAP2 HUWE1 WDR37 CBR1 VIRMA DENND4C CCDC88C KSR1 ZNF106 TBC1D4 OSBPL6 FAM83G MAST1 JAKMIP1 RAPGEF2 DYNC1H1 ARAP2 CCSER1 NIN | 2.77e-06 | 1256 | 172 | 28 | int:YWHAE |
| Interaction | DYNC1H1 interactions | USP36 FLT4 EPPK1 ITSN1 LRRK2 HUWE1 MTHFS VIRMA CCDC88C HEATR6 PRKDC SCLT1 HYDIN DYNC1H1 NIN | 2.15e-05 | 491 | 172 | 15 | int:DYNC1H1 |
| Interaction | KRT8 interactions | RAPGEF6 EPPK1 TNIP2 OVCH1 VIRMA NLN ESYT2 FARSA TBC1D4 LTN1 OTUD4 CDK5RAP2 KRT25 NIN | 2.68e-05 | 441 | 172 | 14 | int:KRT8 |
| Interaction | BRCA2 interactions | CBLL1 SHLD2 POLR2A LRRK2 HUWE1 TRIM29 HELQ VIRMA F8 MKI67 CLSPN DYNC1H1 NIN | 2.70e-05 | 384 | 172 | 13 | int:BRCA2 |
| Interaction | DUSP16 interactions | RAPGEF6 TNIP2 SRGAP2 POLA2 VIRMA DENND4C ARHGEF1 CDK5RAP2 HPS5 DYNC1H1 | 3.80e-05 | 237 | 172 | 10 | int:DUSP16 |
| Interaction | JAK1 interactions | 5.57e-05 | 248 | 172 | 10 | int:JAK1 | |
| Interaction | KCNA3 interactions | RPL28 EPPK1 AFF2 MYO9A LAMA1 LRRK2 MYO18A RNF213 LAMP2 THSD1 HELQ DENND4C PRDM2 CCDC88C ESYT2 FARSA TBC1D4 CDK5RAP2 PRKDC DYNC1H1 | 5.62e-05 | 871 | 172 | 20 | int:KCNA3 |
| Interaction | PMS2 interactions | 6.31e-05 | 80 | 172 | 6 | int:PMS2 | |
| Interaction | CTDP1 interactions | 7.42e-05 | 207 | 172 | 9 | int:CTDP1 | |
| GeneFamily | TEA domain transcription factors | 2.35e-04 | 4 | 114 | 2 | 1183 | |
| GeneFamily | EF-hand domain containing|Spectrins | 8.11e-04 | 7 | 114 | 2 | 1113 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RASA1 ITSN1 EXT1 SRGAP2 TEAD1 WDR37 ZZEF1 BHLHE40 CEMIP MYOF MDN1 ATP11B ARHGEF10 LTN1 OTUD4 ADAM17 OSMR RAPGEF2 ARAP2 SEC14L1 | 1.38e-06 | 856 | 176 | 20 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPGEF6 THSD7A AFF2 CCDC186 LRRK2 CHST1 PRDM2 CEMIP ZNF385D NLN MDN1 PDE4DIP RASGEF1B OSBPL6 ZNF816 OTUD4 MAST1 GOLGA7B HYDIN FRMD3 TPD52L1 CCSER1 | 5.43e-06 | 1106 | 176 | 22 | M39071 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | PIK3AP1 ATP8B4 RNF19B LRRK2 RNF213 LAMP2 EXT1 SRGAP2 ISG20 CBR1 KSR1 MYOF NLN RASGEF1B ADAM17 SRGAP2B RAPGEF2 SCLT1 FRMD3 SEC14L1 | 1.64e-05 | 1012 | 176 | 20 | M40868 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | ITSN1 POLR2A SRGAP2 POLA2 CBR1 ARHGEF10 MKI67 ADAM17 ABCC10 SEC14L1 | 1.86e-05 | 276 | 176 | 10 | M3063 |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN | 5.44e-05 | 195 | 176 | 8 | M4292 | |
| Coexpression | GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP | 5.85e-05 | 197 | 176 | 8 | M9250 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 6.28e-05 | 199 | 176 | 8 | M4635 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP | 6.28e-05 | 199 | 176 | 8 | M8744 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP | 6.28e-05 | 199 | 176 | 8 | M6895 | |
| Coexpression | GSE3982_MAC_VS_TH1_DN | 6.28e-05 | 199 | 176 | 8 | M5511 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP | 6.50e-05 | 200 | 176 | 8 | M8843 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 6.50e-05 | 200 | 176 | 8 | M6095 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | LRRK2 EXT1 SRGAP2 ISG20 CCDC88C SRGAP2B SCLT1 ARAP2 SEC14L1 NIN | 5.46e-09 | 193 | 176 | 10 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 8.35e-08 | 194 | 176 | 9 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-07 | 163 | 176 | 8 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-07 | 167 | 176 | 8 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.65e-07 | 168 | 176 | 8 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.82e-07 | 169 | 176 | 8 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-07 | 178 | 176 | 8 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.90e-07 | 179 | 176 | 8 | c09c3eed43d1aa3b7aa8f3021e6f2737840cde16 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.58e-07 | 185 | 176 | 8 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.58e-07 | 185 | 176 | 8 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.21e-07 | 187 | 176 | 8 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.90e-07 | 189 | 176 | 8 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 8.90e-07 | 189 | 176 | 8 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.26e-07 | 190 | 176 | 8 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.00e-06 | 192 | 176 | 8 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 1.13e-06 | 195 | 176 | 8 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.13e-06 | 195 | 176 | 8 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-06 | 196 | 176 | 8 | 629236f95c838a473b5964a49b7c1b7ad863ea12 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-06 | 197 | 176 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.26e-06 | 198 | 176 | 8 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-06 | 198 | 176 | 8 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.26e-06 | 198 | 176 | 8 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.26e-06 | 198 | 176 | 8 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.31e-06 | 199 | 176 | 8 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.36e-06 | 200 | 176 | 8 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.36e-06 | 200 | 176 | 8 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-06 | 154 | 176 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-06 | 154 | 176 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.84e-06 | 155 | 176 | 7 | cd2ccb4632713b4def3a1064599b78207e2e44c0 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 155 | 176 | 7 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 4.84e-06 | 168 | 176 | 7 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-06 | 174 | 176 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.32e-06 | 175 | 176 | 7 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.32e-06 | 175 | 176 | 7 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 178 | 176 | 7 | 5ac5257d88fa0dc67714881d6f005f6cea925710 | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 7.33e-06 | 179 | 176 | 7 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.33e-06 | 179 | 176 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.88e-06 | 181 | 176 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 182 | 176 | 7 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 182 | 176 | 7 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.17e-06 | 182 | 176 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-06 | 183 | 176 | 7 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.77e-06 | 184 | 176 | 7 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 8.77e-06 | 184 | 176 | 7 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.09e-06 | 185 | 176 | 7 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.41e-06 | 186 | 176 | 7 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-06 | 186 | 176 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-06 | 186 | 176 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.41e-06 | 186 | 176 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 9.75e-06 | 187 | 176 | 7 | 5429ae85942b8ec3895cceb63c663de3c24ca064 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 188 | 176 | 7 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 1.01e-05 | 188 | 176 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 188 | 176 | 7 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-05 | 188 | 176 | 7 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-05 | 189 | 176 | 7 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-05 | 189 | 176 | 7 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.04e-05 | 189 | 176 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.04e-05 | 189 | 176 | 7 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-05 | 189 | 176 | 7 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 190 | 176 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 190 | 176 | 7 | 35248a8be476ea8d06d67c3d98a25be1f7c150b7 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 190 | 176 | 7 | 5f5206f9e725070d865f4c891ff08bb750e58582 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 190 | 176 | 7 | 7ba2be2630183df86de21689289a8620a4cd507e | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.08e-05 | 190 | 176 | 7 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.08e-05 | 190 | 176 | 7 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-05 | 190 | 176 | 7 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 190 | 176 | 7 | 088e3f39a1e5e11354d6e7458e8e6a39f14936b3 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.08e-05 | 190 | 176 | 7 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.08e-05 | 190 | 176 | 7 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 191 | 176 | 7 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 191 | 176 | 7 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | IPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class | 1.16e-05 | 192 | 176 | 7 | e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 192 | 176 | 7 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 1.16e-05 | 192 | 176 | 7 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 192 | 176 | 7 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 192 | 176 | 7 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 192 | 176 | 7 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 192 | 176 | 7 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 1.20e-05 | 193 | 176 | 7 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.20e-05 | 193 | 176 | 7 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-05 | 193 | 176 | 7 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.20e-05 | 193 | 176 | 7 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 194 | 176 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.24e-05 | 194 | 176 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.24e-05 | 194 | 176 | 7 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.24e-05 | 194 | 176 | 7 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 1.24e-05 | 194 | 176 | 7 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-05 | 195 | 176 | 7 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.28e-05 | 195 | 176 | 7 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.28e-05 | 195 | 176 | 7 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.28e-05 | 195 | 176 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-05 | 196 | 176 | 7 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-05 | 196 | 176 | 7 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.32e-05 | 196 | 176 | 7 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 196 | 176 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-05 | 197 | 176 | 7 | 98e34e8612f111bb667a574de1faaa785d318ca4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-05 | 197 | 176 | 7 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 198 | 176 | 7 | 5c82dad416938d5c460069796d808170e7dbc8d9 | |
| ToppCell | ASK428-Endothelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.41e-05 | 198 | 176 | 7 | d69d0ff115298596173a4278897a65007a71f5df | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 198 | 176 | 7 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| Drug | Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A | FLT4 TRIM29 BDKRB2 PITPNM1 NFKB2 ATP6V0A4 PDE4DIP ADAM17 OSMR SPINK5 | 3.12e-06 | 196 | 176 | 10 | 7167_UP |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A | BCORL1 ISG20 THSD1 MYOF ZNF35 ADGRG2 ARHGEF10 IKBKE NFKB2 PDE4DIP | 3.27e-06 | 197 | 176 | 10 | 6797_DN |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A_EA | ISG20 TRIM29 BHLHE40 BDKRB2 CEMIP PITPNM1 ARHGEF10 PDE4DIP OTUD4 | 8.40e-06 | 173 | 176 | 9 | 995_UP |
| Drug | Methamphetamine | CBLL1 PIK3AP1 MYH7 PCNX3 SWT1 ACO1 ZNF189 MYO18A MCC LAMP2 SRGAP2 ISG20 THSD1 POLA2 ZZEF1 CBR1 PRDM2 ARG2 ZNF385D TADA1 TBC1D4 ARHGEF10 ARHGEF1 PDE4DIP MKI67 FASTKD3 SEC14L1 | 1.03e-05 | 1401 | 176 | 27 | ctd:D008694 |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.10e-05 | 194 | 176 | 9 | 2792_DN | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; MCF7; HT_HG-U133A | USP36 CCDC186 RNF19B DYNC2I1 ADGRG2 PDE4DIP OSMR SEC14L1 SPINK5 | 2.28e-05 | 196 | 176 | 9 | 5680_DN |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.28e-05 | 196 | 176 | 9 | 6666_DN | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.28e-05 | 196 | 176 | 9 | 5781_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.47e-05 | 198 | 176 | 9 | 4729_DN | |
| Disease | uric acid measurement | SHLD2 FRAS1 FLT4 RPS6KA4 PCNX3 SWT1 MYO9A TSHR POLA2 QRICH2 CEMIP MYOF ZNF816 | 5.38e-05 | 610 | 169 | 13 | EFO_0004761 |
| Disease | Cleft palate, cleft lip, alcohol exposure measurement, parental genotype effect measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0003959, EFO_0005939, EFO_0009113, HP_0000175 | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | Cerebral ventriculomegaly | 6.72e-04 | 7 | 169 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 6.72e-04 | 7 | 169 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 6.72e-04 | 7 | 169 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 6.72e-04 | 7 | 169 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 6.72e-04 | 7 | 169 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 6.72e-04 | 7 | 169 | 2 | C0549423 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 8.93e-04 | 8 | 169 | 2 | C2677504 | |
| Disease | Congenital Hydrocephalus | 8.93e-04 | 8 | 169 | 2 | C0020256 | |
| Disease | Aqueductal Stenosis | 8.93e-04 | 8 | 169 | 2 | C2936786 | |
| Disease | Hydrocephalus | 1.14e-03 | 9 | 169 | 2 | C0020255 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.15e-03 | 447 | 169 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | Profound Mental Retardation | 1.26e-03 | 139 | 169 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.26e-03 | 139 | 169 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.26e-03 | 139 | 169 | 5 | C0917816 | |
| Disease | theophylline measurement | 1.42e-03 | 10 | 169 | 2 | EFO_0021180 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 2.07e-03 | 12 | 169 | 2 | DOID:3963 (is_marker_for) | |
| Disease | Autosomal Dominant Myotubular Myopathy | 2.44e-03 | 13 | 169 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 2.44e-03 | 13 | 169 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 2.44e-03 | 13 | 169 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 2.44e-03 | 13 | 169 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 2.44e-03 | 13 | 169 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 2.84e-03 | 14 | 169 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 2.84e-03 | 14 | 169 | 2 | C0410207 | |
| Disease | asymmetric dimethylarginine measurement | 2.84e-03 | 14 | 169 | 2 | EFO_0010463 | |
| Disease | asthma, body mass index | 2.84e-03 | 14 | 169 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 3.26e-03 | 15 | 169 | 2 | C3645536 | |
| Disease | serum IgG glycosylation measurement | 3.31e-03 | 523 | 169 | 9 | EFO_0005193 | |
| Disease | Metastatic melanoma | 3.70e-03 | 54 | 169 | 3 | C0278883 | |
| Disease | level of Phosphatidylethanolamine (16:0_20:4) in blood serum | 3.71e-03 | 16 | 169 | 2 | OBA_2045137 | |
| Disease | pyruvate measurement | 4.59e-03 | 268 | 169 | 6 | EFO_0010117 | |
| Disease | Congenital Fiber Type Disproportion | 4.70e-03 | 18 | 169 | 2 | C0546264 | |
| Disease | Hallux valgus | 4.97e-03 | 60 | 169 | 3 | HP_0001822 | |
| Disease | cardiomyopathy (is_implicated_in) | 5.23e-03 | 19 | 169 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 5.23e-03 | 19 | 169 | 2 | OBA_2045140 | |
| Disease | hypertension, white matter hyperintensity measurement | 5.45e-03 | 62 | 169 | 3 | EFO_0000537, EFO_0005665 | |
| Disease | urate measurement | SHLD2 TMCO5A RPS6KA4 PCNX3 MYO9A EXT1 CHST1 TRIM29 QRICH2 CEMIP ZNF816 UHRF1 | 5.60e-03 | 895 | 169 | 12 | EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ARLERKNKTLVHSIT | 86 | Q8N6Q1 | |
| VNSETQLKQHISSRR | 276 | Q9H6B1 | |
| TSTDIVLTITKHLRQ | 256 | P21399 | |
| QLTIRHSSQRNKLIV | 791 | A0FGR8 | |
| RTSISVERQIHKLQD | 371 | P30411 | |
| VTQRRKHASSIKDLT | 681 | Q7Z3E2 | |
| QDERLLLKSHSRTLT | 681 | Q92888 | |
| RTKSLIAQDHRSSLE | 376 | O15013 | |
| LSNIITITQRRLHSD | 1061 | Q96N23 | |
| SLSRLLQTRVHSILK | 6 | P78540 | |
| KHIIIERSNTRSSLA | 286 | Q02641 | |
| LREKQLSHSLRAVST | 96 | Q9HBH7 | |
| ENTRDLKSSQLVTHL | 161 | O14503 | |
| VVILNSTLIHSNRKS | 141 | P51816 | |
| RNLTRNVTVTLKHIN | 546 | Q8IZP9 | |
| QKTSSSQSLEHRLRN | 1366 | Q5H9F3 | |
| TLAIRIQSIHLSSSK | 1086 | A6QL63 | |
| RTQKALILDSVNRHS | 436 | Q8WZ64 | |
| TNLKVRHALSVTSEL | 171 | Q8TF62 | |
| IVSQNLSTRDRKAIH | 746 | Q9C0I3 | |
| RLQQTQSLHSLRSIS | 296 | O00273 | |
| ALSLNKATRSNVRVT | 566 | Q9NQ90 | |
| ATRSQKLVTLSNTLH | 991 | Q9P1Z9 | |
| FLSSRQVRSQKILTH | 31 | Q6ZUJ8 | |
| LEKGSSLHTQRNRRS | 116 | Q8N4T0 | |
| SILSDVHNRLLKQTS | 1091 | Q8WUJ3 | |
| IVLGRTQNTSLSRHK | 551 | Q709F0 | |
| QNLTKSTENHRLRRS | 386 | Q96SN8 | |
| RESLSRKTVSLEHLQ | 1481 | Q96SN8 | |
| SLKVSTNSTRQSLHL | 36 | Q99650 | |
| SEHKNLSRTPSQIIR | 406 | Q01804 | |
| SNKRLRQVSSLVLHI | 586 | P20936 | |
| STKASSQIIRELLHA | 1516 | Q9H0J4 | |
| RVLSERLLHKSIQNS | 131 | Q96AZ6 | |
| AKRNHLRVVDSLQTS | 1586 | P12883 | |
| NERKSEQHLRFLSTL | 606 | O94822 | |
| RSRESLSVHQTLSAI | 1321 | Q8N7Z5 | |
| RQSRVLSQKVIAHSE | 31 | P49914 | |
| KTVLTIAHRLNTILN | 1431 | Q5T3U5 | |
| LQLRVKHANETSLSI | 471 | P23467 | |
| LTSHNRSLKALSVVS | 346 | Q8IZ02 | |
| THRSTAKLLSVLAQV | 4631 | Q9NU22 | |
| RSEIHSINITIERKN | 1941 | Q86XX4 | |
| ISKQVTILNSSALHR | 1501 | Q5T1H1 | |
| SHISTDLRQKNTRAS | 281 | Q2TV78 | |
| STVQVSKLQDLIHRS | 106 | Q8NCE2 | |
| NLIRQTNTHIRSTGK | 1031 | Q9NQ38 | |
| HNLQELRRSASLATK | 6 | Q2TAP0 | |
| QNSVIASRARKTLTA | 381 | Q9UPZ3 | |
| SSLNRELVKSRDQVH | 521 | Q14164 | |
| NLHRSISQNLLKRAS | 366 | P11801 | |
| NRKVSSLHTSRVQRQ | 641 | Q8WVS4 | |
| LTKQVTVHARTLTTL | 896 | Q9P219 | |
| KRVDHSNTRLVTQLD | 1316 | Q9H6A9 | |
| LTRSKSHESQLGNRI | 306 | Q8IVT5 | |
| ATKLHSQLRTTVLAA | 36 | Q765P7 | |
| LLVSLVNRALKSSQH | 766 | Q92614 | |
| HLRTLTSNLNEVRTT | 356 | Q5KU26 | |
| IRHKDVNVRVSSLTL | 571 | Q6AI08 | |
| RHLQTSSLRIKSQEL | 76 | Q5T7B8 | |
| QRSKILTTRLHSLEE | 431 | Q7Z3Z0 | |
| KVGNRSELQHLATSR | 1171 | P09848 | |
| QDKASLTRTLQHRIA | 1961 | Q5S007 | |
| RSHTALLRLNSSTIK | 266 | P13473 | |
| VLKRHQREITRTTLQ | 1661 | P00451 | |
| SLKRHTSLNDLSLTR | 376 | Q96N16 | |
| ALVQRAKTQEHTRTE | 71 | O75676 | |
| SKRVSISRSQHDILQ | 626 | P46013 | |
| RRKRASETTQHINAI | 606 | Q9HAQ2 | |
| RSTHIATKTFQALRI | 276 | A6NJ78 | |
| AQRSLTAHSSREKIV | 356 | Q0VAM2 | |
| THRTVLNQILRQSTT | 3961 | Q7Z6Z7 | |
| TSSQRDSRQSIHILE | 26 | Q9BZF3 | |
| RKITKQSNLLHTSRS | 1096 | Q9Y2H9 | |
| TFRISTRKHSNLITV | 281 | Q75N03 | |
| TQSRSSHSLNKQLII | 361 | A2A2Y4 | |
| RLTKSSEIRHQQSAE | 746 | P23508 | |
| VRSKHTQTILLSNRT | 4641 | Q4G0P3 | |
| TLRSQVAHSSKLDRN | 581 | P0C671 | |
| VQRKAVSAIHSLLSS | 1181 | Q8NF50 | |
| STIRSIHQDKILALR | 391 | Q16394 | |
| QQNSLHRDSLVTLKR | 556 | Q15811 | |
| NSLSKRNVSLTRSHS | 1626 | Q5VZ89 | |
| SAKHTSLRRQLQLED | 96 | Q494V2 | |
| VTVLSRIHARKLSEQ | 201 | P16152 | |
| STLHRNILSSDLIKI | 436 | O60336 | |
| VHQRDVTRSLIKSKI | 1816 | Q14204 | |
| ISVLNAETSSRHSLR | 526 | Q8NFI3 | |
| ETSQSQSHTLAIRKL | 771 | Q6IA86 | |
| DTLRIIRLSHSASKQ | 866 | Q8NDH2 | |
| TVTHRIRKQSLQSQI | 181 | Q96LA5 | |
| DHLSRRQAKQIVSSA | 1051 | Q8TDG4 | |
| VQKNSLNSRERTLHI | 81 | Q92503 | |
| DAQSLISISLRKIHS | 6 | Q5T953 | |
| ISISLRKIHSSRTQR | 11 | Q5T953 | |
| AQLSSKTSRSLHVRV | 1601 | Q13029 | |
| TTRVRTVLNEKQLHT | 191 | Q96A47 | |
| RIKIRDTSQASAQHQ | 446 | A6ND36 | |
| IKLRNAIHLSNLTVS | 166 | P0DTE0 | |
| KQTREQLHSISDSVL | 361 | Q14134 | |
| TSEQITHRLSKLSER | 206 | Q96M34 | |
| QQRAQTLRVRTKHTS | 256 | Q6ZMZ0 | |
| EILRNNTHLALTVKT | 596 | Q8TEU7 | |
| LSRNKETELLRQTHS | 166 | Q8NHS9 | |
| LDEARKNLLRTHTTS | 316 | Q9Y285 | |
| DSSIRKQSRHRVIIQ | 791 | Q9UPZ6 | |
| NHLKDILTSVVSRRK | 181 | Q96BN2 | |
| TNLRSKVSHLAISTL | 541 | Q6ZUX3 | |
| LTLRNTTLFLRHNKD | 86 | P0C866 | |
| THSREKVRQLESNLL | 1871 | Q8N4C6 | |
| TRTSQMQELHKSLRS | 206 | O43172 | |
| ISNQLSITTKIAREH | 186 | Q0VDG4 | |
| KITRLSQSSNREHLV | 966 | Q7RTY7 | |
| KESHLDTLSRAQLTQ | 481 | Q14CZ7 | |
| ASLSRVNTTLRETHQ | 2041 | P25391 | |
| NSRVIDQKTLHTLRV | 1861 | P58107 | |
| SEVQRRIHLQTKSDS | 176 | Q53H47 | |
| NIESQKIHSSRLSDI | 101 | Q86V20 | |
| LLLNQVKRESRDHTT | 101 | P0DMP2 | |
| TRKQVSSHIQVLARR | 96 | Q15562 | |
| TSDRFSRILKHILTQ | 491 | Q14181 | |
| TTRVRTVLNEKQLHT | 181 | P61371 | |
| SLNVTRQKTEHLLSD | 276 | Q5T5J6 | |
| LRIRSTQGQHKAIST | 226 | Q8NH85 | |
| TINKNARATLSSIRH | 81 | P46779 | |
| QISRHNETKALSETL | 226 | Q8N1H7 | |
| RLQKRHQQLESESRT | 1456 | Q9NRC6 | |
| SVVIQASKSRRHRQV | 271 | Q16533 | |
| SLSNIQQHSVRKRDL | 46 | P78536 | |
| RKRDLQTSTHVETLL | 56 | P78536 | |
| NLSRKTHILILATTR | 56 | O43916 | |
| LLDQTTSHTSRLKAR | 16 | O75596 | |
| LKQLHSETQRLIRES | 286 | Q9HAW4 | |
| TEHQRNSSKILRFIS | 326 | Q9Y2G3 | |
| LRQIVLSKVDQSLHT | 576 | Q9BYT8 | |
| TRQTSHLQARSLSEI | 241 | Q5QJE6 | |
| SLANETHQLRRTLTA | 146 | Q8NFZ5 | |
| VKIRNVTSNHRASDT | 911 | O00562 | |
| EILRNNTHLSITVKT | 451 | Q9Y4G8 | |
| RHSQDLSSKRLNDTV | 1181 | Q63HN8 | |
| KTFTRSSNLIVHQRI | 341 | P13682 | |
| KTFSVSSTLIRHQRI | 211 | O75820 | |
| QSSSLLQRQTLHTRE | 161 | Q9NXT0 | |
| SKRFTIHRSSNVLTL | 301 | Q9H9J4 | |
| IHRSSNVLTLSLKRF | 306 | Q9H9J4 | |
| VSVRHSQTILNAKSR | 161 | Q6ZNA4 | |
| SQTILNAKSRSHSAR | 166 | Q6ZNA4 | |
| LNRSSADLRIRKTQH | 106 | Q16623 | |
| ADLRIRKTQHSTLSR | 111 | Q16623 | |
| NILHKTDQTLRRIVS | 271 | Q8IV42 | |
| LEHTTLRKVTANTAI | 1161 | P24928 | |
| SQTLIRKSQARHVGS | 621 | Q9NS62 | |
| LLLNQVKRESRDHTT | 101 | O75044 | |
| LNSISRHSSLKNRLD | 901 | O75044 | |
| ERRSQQTHTELSSIL | 281 | P35916 | |
| KTFRQTSQVILHLRT | 281 | Q6AZW8 | |
| SELSRQKLHTQELLS | 611 | Q96NL6 | |
| KTQHLSAARSSDLRL | 1371 | P11277 | |
| TNVSLQRISLHKASE | 806 | Q86WI1 | |
| AKLVIQRHLSSLTDN | 476 | O60343 | |
| LHQSRLTKLQSVQAL | 3121 | P78527 | |
| TTLRQVLSAKERHLV | 51 | Q16890 | |
| ILRASHRKSQLQASR | 661 | Q9HBG4 | |
| QKRKSHSLSIRRTNS | 16 | Q9Y2I8 | |
| RQTHTVDSLSRLTKV | 11 | Q96T88 | |
| HKSDRLISLQSASVV | 351 | Q86TV6 | |
| DQSLSHRSVVKVLSL | 1566 | O43149 | |
| KSFTQSSGLIRHQRI | 261 | O15535 | |
| VLHAESTKTSLLRSQ | 766 | Q502W6 | |
| TRKQVSSHIQVLARR | 86 | P28347 | |
| TAEILHSRNKRLSIS | 171 | Q8N7C4 | |
| KTFTLSATLLRHQRT | 381 | Q9UEG4 | |
| NSSALHSLLKRVVST | 1371 | Q69YN4 | |
| QLIHKRRATSASRSQ | 281 | Q70J99 | |
| ASLQRDLTRHISLKS | 726 | Q9H2Y7 | |
| KSFLTSSRLIQHIRT | 371 | Q9BUY5 | |
| ASKRFTIHRTSNVLT | 311 | Q9P275 | |
| TIHRTSNVLTLSLKR | 316 | Q9P275 | |
| ESQRISCRLKTHISN | 191 | Q0VGE8 | |
| SQIKARLSTVHTREK | 101 | Q9UK12 | |
| TESEIKRRSHLQLLN | 241 | Q7Z7D3 | |
| SKVTHIEIRNTRNLT | 101 | P16473 | |
| SLKHLTRLTLQDRIT | 861 | B2RTY4 | |
| TRLTLQDRITKSLLH | 866 | B2RTY4 | |
| QIRKLRSRSLSQIHE | 721 | Q9NZM1 | |
| VSKQERLLQSTTEHL | 2286 | Q5VU43 | |
| SQLTRTHDVLKKART | 2316 | Q5VU43 | |
| RQKIRQLTQELSVSH | 126 | P0CAP1 | |
| THLVTKLRANVNART | 651 | Q00653 |